Company: STAA
Filing Date: 2025-11-03
Form Type: PX14A6G
Source: 0001193125-25-261591
Chunk: 0

Company: STAAR SURGICAL CO
Filing Date: 2025-11-03
Form: PX14A6G
Chunk 0
---
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EXEMPT SOLICITATION Submitted Pursuant to Rule 14a-6(g) (Amendment No. _)

| 1. | Name of the Registrant: |

STAAR SURGICAL CO

| 2. | Name of Person Relying on Exemption: |

Yunqi Capital Limited

| 3. | Address of Person Relying on Exemption: |

Unit 3703, 37/F, AIA Tower, 183 Electric Road, North Point, Hong Kong

| 4. | Written Materials. The following written material is attached hereto: |

Press release, dated October 31, 2025, attached hereto as Exhibit 1. * * * Written material is submitted pursuant to Rule 14a-6(g)(1)promulgated under the Securities Exchange Act of 1934, as amended. This is not a solicitation of authority to vote any proxy. Yunqi Capital Limited (together with its affiliates, “Yunqi Capital”) is not asking for your proxy card and will not accept proxy cards if sent. The cost of this filing is being borne entirely by Yunqi Capital. PLEASE NOTE: Yunqi Capital is not asking for your proxy card and cannot accept your proxy card. Please DO NOT send us your proxy card. (Written material follows on next page)

Exhibit 1 Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon Questions Company’s Adjournment and Postponement of the Special Meeting Without Substantive Explanation STAAR Should Heed the Strong Shareholder Opposition Already Expressed Through the Special Meeting Voting Process HONG KONG, October 31, 2025 – Yunqi Capital Limited (together with its affiliates and the funds it advises, “Yunqi Capital”), an investment management firm and 5.1% shareholder of STAAR Surgical Company (“STAAR” or the “Company”) (NASDAQ:STAA), today released the following letter to the Board of Directors of STAAR after its decision to postpone STAAR’s Special Meeting of Stockholders to vote on the proposed sale to Alcon Inc. (SIX/NYSE:ALC) on the terms announced on August 5, 2025. The text of the letter to the Board is as follows: October 31, 2025 STAAR Surgical Company